| 
																	
																	
																		 John Dornhoffer
 
																		 Concepts  (391)
																		
																	 
																		Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months. 
																			
																					
    Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
     | Name | Number of Publications | Most Recent Publication | Publications by All Authors | Concept Score | Why? | 
|---|
 | Tympanoplasty | 23 | 2020 | 57 | 6.950 | Why? |  | Cochlear Implantation | 12 | 2025 | 81 | 4.950 | Why? |  | Mastoid | 20 | 2019 | 51 | 4.540 | Why? |  | Cochlear Implants | 9 | 2022 | 67 | 4.070 | Why? |  | Hearing Loss, Conductive | 16 | 2019 | 55 | 3.730 | Why? |  | Hearing Aids | 9 | 2017 | 70 | 3.170 | Why? |  | Ossicular Replacement | 13 | 2024 | 29 | 2.870 | Why? |  | Hearing Loss, Sensorineural | 12 | 2025 | 79 | 2.850 | Why? |  | Cholesteatoma, Middle Ear | 16 | 2017 | 32 | 2.740 | Why? |  | Tinnitus | 13 | 2017 | 60 | 2.400 | Why? |  | Stapes Surgery | 8 | 2020 | 24 | 2.350 | Why? |  | Cartilage | 12 | 2020 | 47 | 2.340 | Why? |  | Otologic Surgical Procedures | 12 | 2023 | 37 | 2.250 | Why? |  | Treatment Outcome | 54 | 2025 | 5422 | 2.250 | Why? |  | Hearing Loss | 6 | 2023 | 96 | 1.890 | Why? |  | Transcranial Magnetic Stimulation | 10 | 2017 | 72 | 1.850 | Why? |  | Tympanic Membrane Perforation | 6 | 2020 | 20 | 1.800 | Why? |  | Retrospective Studies | 54 | 2024 | 6607 | 1.770 | Why? |  | Ear Ossicles | 8 | 2017 | 16 | 1.750 | Why? |  | Hearing | 11 | 2024 | 63 | 1.710 | Why? |  | Tympanic Membrane | 12 | 2020 | 37 | 1.700 | Why? |  | Ossicular Prosthesis | 9 | 2020 | 19 | 1.660 | Why? |  | Hearing Loss, Unilateral | 4 | 2016 | 12 | 1.640 | Why? |  | Postoperative Complications | 18 | 2025 | 1068 | 1.610 | Why? |  | Child | 50 | 2025 | 7248 | 1.590 | Why? |  | Otorhinolaryngologic Surgical Procedures | 4 | 2019 | 34 | 1.530 | Why? |  | Adolescent | 44 | 2024 | 6739 | 1.510 | Why? |  | Ear Diseases | 5 | 2023 | 28 | 1.420 | Why? |  | Meniere Disease | 10 | 2024 | 21 | 1.410 | Why? |  | Osseointegration | 3 | 2017 | 29 | 1.390 | Why? |  | Humans | 124 | 2025 | 52483 | 1.390 | Why? |  | Bone Conduction | 11 | 2017 | 26 | 1.330 | Why? |  | Male | 80 | 2025 | 26761 | 1.320 | Why? |  | Adult | 65 | 2024 | 14161 | 1.320 | Why? |  | Otolaryngology | 4 | 2019 | 61 | 1.310 | Why? |  | Female | 80 | 2025 | 28171 | 1.280 | Why? |  | Child, Preschool | 28 | 2025 | 4076 | 1.220 | Why? |  | Ear Canal | 6 | 2013 | 13 | 1.180 | Why? |  | Middle Aged | 54 | 2024 | 13028 | 1.180 | Why? |  | Aged | 44 | 2024 | 10121 | 1.120 | Why? |  | Patient Satisfaction | 3 | 2018 | 284 | 1.040 | Why? |  | Semicircular Canals | 3 | 2019 | 12 | 0.970 | Why? |  | Young Adult | 20 | 2024 | 4329 | 0.960 | Why? |  | Audiometry, Pure-Tone | 19 | 2024 | 53 | 0.940 | Why? |  | Reoperation | 13 | 2020 | 465 | 0.870 | Why? |  | Smoking | 3 | 2016 | 520 | 0.870 | Why? |  | Otitis Media, Suppurative | 2 | 2016 | 7 | 0.840 | Why? |  | Audiometry | 7 | 2020 | 35 | 0.800 | Why? |  | Otosclerosis | 2 | 2020 | 10 | 0.800 | Why? |  | Costs and Cost Analysis | 3 | 2018 | 95 | 0.790 | Why? |  | Malleus | 4 | 2019 | 11 | 0.780 | Why? |  | Surgical Flaps | 4 | 2016 | 110 | 0.760 | Why? |  | Cleft Palate | 3 | 2021 | 79 | 0.760 | Why? |  | Craniocerebral Trauma | 1 | 2022 | 60 | 0.750 | Why? |  | Auditory Threshold | 9 | 2025 | 54 | 0.730 | Why? |  | Temporal Bone | 6 | 2013 | 34 | 0.720 | Why? |  | Biocompatible Materials | 6 | 2005 | 67 | 0.720 | Why? |  | Follow-Up Studies | 20 | 2024 | 2279 | 0.700 | Why? |  | Aged, 80 and over | 13 | 2019 | 3392 | 0.700 | Why? |  | Neuroma, Acoustic | 5 | 2008 | 22 | 0.650 | Why? |  | Receptors, Atrial Natriuretic Factor | 3 | 2005 | 8 | 0.640 | Why? |  | Ear Cartilage | 2 | 2016 | 5 | 0.620 | Why? |  | Quality of Life | 2 | 2019 | 879 | 0.620 | Why? |  | Neuronal Plasticity | 1 | 2019 | 45 | 0.610 | Why? |  | Patient Preference | 1 | 2019 | 43 | 0.600 | Why? |  | Intraoperative Period | 1 | 2018 | 46 | 0.590 | Why? |  | Eustachian Tube | 3 | 2023 | 13 | 0.590 | Why? |  | Neurotology | 1 | 2018 | 8 | 0.580 | Why? |  | Space Motion Sickness | 3 | 2012 | 5 | 0.560 | Why? |  | Ear, Inner | 5 | 2013 | 18 | 0.530 | Why? |  | Valsalva Maneuver | 1 | 2016 | 10 | 0.530 | Why? |  | Child Behavior Disorders | 1 | 2017 | 77 | 0.520 | Why? |  | Otitis Media with Effusion | 2 | 2010 | 16 | 0.510 | Why? |  | Child Behavior | 1 | 2017 | 108 | 0.510 | Why? |  | Treatment Failure | 1 | 2016 | 122 | 0.490 | Why? |  | Positron-Emission Tomography | 4 | 2011 | 301 | 0.480 | Why? |  | Temporal Lobe | 4 | 2017 | 70 | 0.470 | Why? |  | Stapes | 5 | 2020 | 12 | 0.470 | Why? |  | Equipment Failure | 2 | 2013 | 64 | 0.470 | Why? |  | Vertigo | 6 | 2020 | 18 | 0.460 | Why? |  | Labyrinth Diseases | 4 | 2000 | 7 | 0.460 | Why? |  | Durapatite | 3 | 2003 | 23 | 0.450 | Why? |  | Atrial Natriuretic Factor | 2 | 2005 | 25 | 0.440 | Why? |  | Ear, Middle | 4 | 2018 | 19 | 0.440 | Why? |  | Arousal | 5 | 2007 | 101 | 0.430 | Why? |  | Regional Blood Flow | 2 | 2011 | 109 | 0.420 | Why? |  | Cerebellopontine Angle | 2 | 2008 | 6 | 0.410 | Why? |  | Cerebellar Neoplasms | 2 | 2008 | 21 | 0.400 | Why? |  | Recurrence | 7 | 2017 | 672 | 0.390 | Why? |  | Postoperative Period | 3 | 2019 | 170 | 0.390 | Why? |  | Middle Ear Ventilation | 3 | 2002 | 16 | 0.390 | Why? |  | Endolymphatic Sac | 4 | 2002 | 7 | 0.390 | Why? |  | Audiometry, Evoked Response | 5 | 2006 | 7 | 0.380 | Why? |  | Antiemetics | 3 | 2012 | 32 | 0.370 | Why? |  | Patient Selection | 1 | 2012 | 259 | 0.360 | Why? |  | Prosthesis Implantation | 2 | 2008 | 51 | 0.350 | Why? |  | Infant | 6 | 2018 | 3733 | 0.350 | Why? |  | Evoked Potentials, Auditory | 4 | 2006 | 90 | 0.340 | Why? |  | Tomography, X-Ray Computed | 9 | 2013 | 1165 | 0.330 | Why? |  | Chronic Disease | 6 | 2016 | 586 | 0.330 | Why? |  | Proteus mirabilis | 1 | 2009 | 2 | 0.320 | Why? |  | Proteus Infections | 1 | 2009 | 4 | 0.320 | Why? |  | Bacteroidaceae Infections | 1 | 2009 | 4 | 0.320 | Why? |  | Bacteroides | 1 | 2009 | 14 | 0.320 | Why? |  | Brain Abscess | 1 | 2009 | 10 | 0.320 | Why? |  | Cerebellar Diseases | 1 | 2009 | 17 | 0.310 | Why? |  | Fistula | 3 | 2000 | 27 | 0.310 | Why? |  | Time Factors | 10 | 2013 | 2968 | 0.300 | Why? |  | Risk Factors | 7 | 2024 | 3889 | 0.290 | Why? |  | Blood Glucose | 1 | 2011 | 473 | 0.290 | Why? |  | Randomized Controlled Trials as Topic | 2 | 2024 | 595 | 0.290 | Why? |  | Electric Impedance | 2 | 2018 | 49 | 0.290 | Why? |  | Succinate Dehydrogenase | 1 | 2008 | 22 | 0.290 | Why? |  | Paraganglioma | 1 | 2008 | 14 | 0.290 | Why? |  | Prosthesis Design | 3 | 2014 | 256 | 0.280 | Why? |  | Neoplasms, Multiple Primary | 1 | 2008 | 44 | 0.280 | Why? |  | Vestibule, Labyrinth | 2 | 2004 | 14 | 0.280 | Why? |  | Facial Nerve | 3 | 2023 | 17 | 0.280 | Why? |  | DNA Mutational Analysis | 1 | 2008 | 180 | 0.280 | Why? |  | Prognosis | 6 | 2019 | 2099 | 0.270 | Why? |  | United States | 6 | 2024 | 5192 | 0.270 | Why? |  | Bone Matrix | 2 | 2004 | 16 | 0.260 | Why? |  | Databases, Factual | 3 | 2024 | 706 | 0.260 | Why? |  | Arkansas | 4 | 2017 | 2028 | 0.260 | Why? |  | Drainage | 3 | 2008 | 87 | 0.260 | Why? |  | Attention | 3 | 2017 | 168 | 0.250 | Why? |  | Equipment Design | 5 | 2010 | 293 | 0.240 | Why? |  | Cholesteatoma | 2 | 2012 | 6 | 0.240 | Why? |  | Keratitis | 1 | 2025 | 12 | 0.240 | Why? |  | Cochlear Nerve | 1 | 2025 | 7 | 0.240 | Why? |  | Noise | 3 | 2008 | 41 | 0.240 | Why? |  | Posture | 2 | 2008 | 66 | 0.240 | Why? |  | Deafness | 1 | 2025 | 35 | 0.230 | Why? |  | Histamine H1 Antagonists | 1 | 2004 | 9 | 0.230 | Why? |  | GABA Modulators | 1 | 2004 | 10 | 0.230 | Why? |  | Up-Regulation | 2 | 2005 | 454 | 0.230 | Why? |  | Genetic Predisposition to Disease | 1 | 2008 | 528 | 0.230 | Why? |  | Muscarinic Antagonists | 1 | 2004 | 25 | 0.230 | Why? |  | Memory Disorders | 1 | 2004 | 49 | 0.230 | Why? |  | Auditory Brain Stem Implants | 1 | 2024 | 2 | 0.230 | Why? |  | Transplants | 1 | 2004 | 19 | 0.220 | Why? |  | Hearing Disorders | 3 | 1999 | 11 | 0.220 | Why? |  | Memory, Short-Term | 1 | 2004 | 72 | 0.220 | Why? |  | Evoked Potentials, Auditory, Brain Stem | 6 | 2001 | 24 | 0.220 | Why? |  | Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 178 | 0.220 | Why? |  | Bell Palsy | 1 | 2023 | 5 | 0.220 | Why? |  | Facial Paralysis | 1 | 2023 | 25 | 0.210 | Why? |  | Cognition Disorders | 1 | 2004 | 196 | 0.210 | Why? |  | Prostheses and Implants | 2 | 2002 | 55 | 0.210 | Why? |  | Myringoplasty | 2 | 2013 | 6 | 0.200 | Why? |  | Decision Making | 2 | 2017 | 282 | 0.200 | Why? |  | Cross-Over Studies | 4 | 2017 | 238 | 0.200 | Why? |  | Ceramics | 1 | 2002 | 5 | 0.200 | Why? |  | Foreign Bodies | 1 | 2023 | 66 | 0.200 | Why? |  | Titanium | 1 | 2002 | 36 | 0.200 | Why? |  | Endoscopy | 3 | 2023 | 123 | 0.200 | Why? |  | Reaction Time | 8 | 2006 | 209 | 0.200 | Why? |  | Guanylate Cyclase | 1 | 2002 | 9 | 0.190 | Why? |  | Cicatrix | 1 | 2002 | 42 | 0.190 | Why? |  | Nasopharyngeal Neoplasms | 1 | 2002 | 6 | 0.190 | Why? |  | Ear, External | 1 | 2002 | 9 | 0.190 | Why? |  | Action Potentials | 3 | 2017 | 120 | 0.190 | Why? |  | Skull Neoplasms | 1 | 2002 | 5 | 0.190 | Why? |  | Bone Regeneration | 1 | 2002 | 70 | 0.190 | Why? |  | Ear Neoplasms | 1 | 2002 | 10 | 0.190 | Why? |  | Speech Perception | 1 | 2022 | 98 | 0.180 | Why? |  | Incus | 2 | 2012 | 4 | 0.180 | Why? |  | Diagnosis, Differential | 3 | 2016 | 1046 | 0.180 | Why? |  | Healthcare Disparities | 1 | 2024 | 299 | 0.180 | Why? |  | Velopharyngeal Insufficiency | 1 | 2021 | 18 | 0.180 | Why? |  | Electroencephalography | 2 | 2002 | 312 | 0.170 | Why? |  | Barotrauma | 1 | 2000 | 1 | 0.170 | Why? |  | Risk Assessment | 3 | 2013 | 1327 | 0.170 | Why? |  | Hospitals, University | 1 | 2000 | 75 | 0.170 | Why? |  | Sleep | 1 | 2002 | 187 | 0.170 | Why? |  | Antibodies | 2 | 2015 | 159 | 0.170 | Why? |  | Patient Admission | 1 | 2000 | 78 | 0.170 | Why? |  | Ambulatory Surgical Procedures | 1 | 2000 | 52 | 0.160 | Why? |  | Gelatin Sponge, Absorbable | 1 | 1999 | 4 | 0.160 | Why? |  | Disease Models, Animal | 3 | 2001 | 1478 | 0.160 | Why? |  | Hemostatics | 1 | 1999 | 17 | 0.160 | Why? |  | Psychomotor Performance | 3 | 2017 | 126 | 0.160 | Why? |  | Mastoiditis | 1 | 1999 | 7 | 0.160 | Why? |  | Pain Measurement | 2 | 2011 | 256 | 0.150 | Why? |  | Severity of Illness Index | 4 | 2006 | 1026 | 0.150 | Why? |  | Gerbillinae | 3 | 2003 | 9 | 0.150 | Why? |  | Evoked Potentials | 1 | 2018 | 67 | 0.150 | Why? |  | Pilot Projects | 4 | 2017 | 721 | 0.150 | Why? |  | Operative Time | 1 | 2018 | 77 | 0.150 | Why? |  | Hospital Costs | 1 | 2018 | 72 | 0.140 | Why? |  | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 582 | 0.140 | Why? |  | Electrophysiological Phenomena | 1 | 2017 | 19 | 0.140 | Why? |  | Fluorodeoxyglucose F18 | 2 | 2011 | 188 | 0.140 | Why? |  | Meclizine | 3 | 2012 | 5 | 0.140 | Why? |  | Hearing Tests | 2 | 2014 | 27 | 0.140 | Why? |  | Lorazepam | 3 | 2012 | 12 | 0.140 | Why? |  | Promethazine | 3 | 2012 | 10 | 0.140 | Why? |  | Evidence-Based Medicine | 2 | 2016 | 261 | 0.140 | Why? |  | Immune System Diseases | 1 | 1997 | 8 | 0.130 | Why? |  | Algorithms | 3 | 2020 | 672 | 0.130 | Why? |  | Cross-Sectional Studies | 2 | 2023 | 1678 | 0.130 | Why? |  | Perception | 1 | 2017 | 120 | 0.130 | Why? |  | Thalamus | 2 | 2006 | 35 | 0.130 | Why? |  | Granulation Tissue | 2 | 2009 | 10 | 0.120 | Why? |  | Animals | 9 | 2023 | 13505 | 0.120 | Why? |  | Clinical Trials as Topic | 2 | 2012 | 467 | 0.120 | Why? |  | Fibroma, Ossifying | 1 | 1995 | 2 | 0.120 | Why? |  | Fibrous Dysplasia of Bone | 1 | 1995 | 6 | 0.120 | Why? |  | Cochlear Diseases | 1 | 1995 | 4 | 0.120 | Why? |  | Nanocapsules | 1 | 2015 | 7 | 0.120 | Why? |  | Paranasal Sinus Neoplasms | 1 | 1995 | 20 | 0.120 | Why? |  | Cochlea | 1 | 1995 | 17 | 0.120 | Why? |  | Rotation | 3 | 2004 | 44 | 0.120 | Why? |  | Indocyanine Green | 1 | 2015 | 33 | 0.110 | Why? |  | Acoustic Stimulation | 1 | 1995 | 93 | 0.110 | Why? |  | Photochemotherapy | 1 | 2015 | 34 | 0.110 | Why? |  | Magnetic Resonance Imaging | 4 | 2017 | 1546 | 0.110 | Why? |  | Rats, Inbred Lew | 2 | 2005 | 48 | 0.110 | Why? |  | Second-Look Surgery | 1 | 2013 | 3 | 0.110 | Why? |  | Antigen-Antibody Complex | 1 | 1993 | 35 | 0.110 | Why? |  | Biofeedback, Psychology | 1 | 2013 | 18 | 0.110 | Why? |  | Age Factors | 2 | 2010 | 1132 | 0.110 | Why? |  | Electric Stimulation | 1 | 2013 | 107 | 0.110 | Why? |  | Research Design | 2 | 2013 | 359 | 0.110 | Why? |  | Dilatation | 2 | 2023 | 27 | 0.100 | Why? |  | Vestibular Diseases | 1 | 1993 | 8 | 0.100 | Why? |  | Bone Demineralization Technique | 2 | 2004 | 3 | 0.100 | Why? |  | Wound Healing | 3 | 2003 | 219 | 0.100 | Why? |  | Catheterization | 2 | 2023 | 96 | 0.100 | Why? |  | Diffusion Magnetic Resonance Imaging | 1 | 2013 | 133 | 0.100 | Why? |  | Functional Laterality | 2 | 2012 | 90 | 0.100 | Why? |  | Saccule and Utricle | 1 | 2012 | 2 | 0.100 | Why? |  | Reflex, Vestibulo-Ocular | 1 | 2012 | 5 | 0.100 | Why? |  | Prospective Studies | 1 | 2018 | 2481 | 0.100 | Why? |  | Postoperative Care | 2 | 2003 | 104 | 0.090 | Why? |  | Dose-Response Relationship, Drug | 2 | 2005 | 1378 | 0.090 | Why? |  | Round Window, Ear | 2 | 2005 | 6 | 0.090 | Why? |  | Homeostasis | 2 | 2002 | 201 | 0.090 | Why? |  | Fibrosis | 3 | 2012 | 196 | 0.090 | Why? |  | Rats | 4 | 2005 | 3220 | 0.090 | Why? |  | Cognition | 1 | 2013 | 331 | 0.080 | Why? |  | Suture Anchors | 1 | 2010 | 11 | 0.080 | Why? |  | Prefrontal Cortex | 3 | 2017 | 85 | 0.080 | Why? |  | Case-Control Studies | 2 | 2006 | 1201 | 0.080 | Why? |  | Logistic Models | 1 | 2012 | 925 | 0.080 | Why? |  | Infusions, Intravenous | 2 | 2009 | 220 | 0.080 | Why? |  | Vestibular Function Tests | 2 | 2012 | 7 | 0.080 | Why? |  | Double-Blind Method | 2 | 2017 | 713 | 0.080 | Why? |  | Databases as Topic | 2 | 2000 | 39 | 0.080 | Why? |  | Speech Intelligibility | 1 | 2008 | 14 | 0.080 | Why? |  | Television | 1 | 2008 | 16 | 0.080 | Why? |  | Equipment Safety | 1 | 2008 | 11 | 0.080 | Why? |  | Dominance, Cerebral | 1 | 2008 | 25 | 0.070 | Why? |  | Transcutaneous Electric Nerve Stimulation | 1 | 2008 | 10 | 0.070 | Why? |  | Otitis Media | 1 | 2008 | 29 | 0.070 | Why? |  | Retreatment | 1 | 2008 | 58 | 0.070 | Why? |  | Reading | 1 | 2008 | 73 | 0.070 | Why? |  | Consensus | 2 | 2020 | 181 | 0.070 | Why? |  | Proline | 1 | 2008 | 31 | 0.070 | Why? |  | Eating | 1 | 2008 | 159 | 0.070 | Why? |  | Codon | 1 | 2008 | 43 | 0.070 | Why? |  | Secondary Prevention | 1 | 2008 | 84 | 0.070 | Why? |  | Amino Acid Substitution | 1 | 2008 | 82 | 0.070 | Why? |  | Activities of Daily Living | 1 | 2008 | 182 | 0.070 | Why? |  | Appendicitis | 1 | 1988 | 66 | 0.070 | Why? |  | Leucine | 1 | 2008 | 114 | 0.070 | Why? |  | Brain Stem | 2 | 2006 | 57 | 0.070 | Why? |  | Chromosome Deletion | 1 | 2008 | 142 | 0.070 | Why? |  | Alleles | 1 | 2008 | 276 | 0.070 | Why? |  | Auditory Cortex | 1 | 2006 | 19 | 0.070 | Why? |  | Base Sequence | 1 | 2008 | 640 | 0.070 | Why? |  | Radiography | 1 | 2008 | 470 | 0.070 | Why? |  | Therapy, Computer-Assisted | 1 | 2006 | 31 | 0.070 | Why? |  | Autoantibodies | 2 | 1997 | 121 | 0.070 | Why? |  | Feasibility Studies | 1 | 2008 | 406 | 0.060 | Why? |  | Genotype | 1 | 2008 | 566 | 0.060 | Why? |  | Radiosurgery | 1 | 2008 | 131 | 0.060 | Why? |  | Connective Tissue | 2 | 1997 | 10 | 0.060 | Why? |  | Task Performance and Analysis | 1 | 2006 | 52 | 0.060 | Why? |  | Silicones | 1 | 2005 | 9 | 0.060 | Why? |  | Energy Metabolism | 1 | 2008 | 302 | 0.060 | Why? |  | Dermatitis, Allergic Contact | 1 | 2005 | 12 | 0.060 | Why? |  | Radiopharmaceuticals | 1 | 2006 | 204 | 0.060 | Why? |  | Electrophoresis, Agar Gel | 1 | 2005 | 12 | 0.060 | Why? |  | Buffers | 1 | 2005 | 9 | 0.060 | Why? |  | Cohort Studies | 2 | 2013 | 1542 | 0.060 | Why? |  | Cerebrospinal Fluid Otorrhea | 2 | 1995 | 3 | 0.060 | Why? |  | Injections | 1 | 2005 | 61 | 0.060 | Why? |  | Phosphates | 1 | 2005 | 49 | 0.060 | Why? |  | Sodium Chloride | 1 | 2005 | 56 | 0.060 | Why? |  | Prednisolone | 2 | 1995 | 56 | 0.060 | Why? |  | Protein Isoforms | 1 | 2005 | 123 | 0.060 | Why? |  | Drug Combinations | 1 | 2005 | 132 | 0.060 | Why? |  | Emergency Service, Hospital | 1 | 2009 | 522 | 0.060 | Why? |  | Europe | 1 | 2024 | 87 | 0.060 | Why? |  | Auditory Brain Stem Implantation | 1 | 2024 | 2 | 0.060 | Why? |  | Pregnancy Complications | 1 | 1988 | 400 | 0.050 | Why? |  | Single-Blind Method | 2 | 2013 | 116 | 0.050 | Why? |  | Neuropsychological Tests | 1 | 2004 | 338 | 0.050 | Why? |  | Anti-Bacterial Agents | 1 | 2009 | 807 | 0.050 | Why? |  | Densitometry | 1 | 2002 | 13 | 0.050 | Why? |  | Electrophoresis | 1 | 2002 | 16 | 0.050 | Why? |  | Sound Spectrography | 1 | 2002 | 14 | 0.050 | Why? |  | Glycerol | 1 | 2002 | 19 | 0.050 | Why? |  | Bone Substitutes | 1 | 2002 | 8 | 0.050 | Why? |  | Matched-Pair Analysis | 1 | 2002 | 11 | 0.050 | Why? |  | Motion Sickness | 1 | 2002 | 7 | 0.050 | Why? |  | Reticular Formation | 1 | 2002 | 28 | 0.050 | Why? |  | Laser Therapy | 1 | 2002 | 82 | 0.050 | Why? |  | Swine | 1 | 2023 | 428 | 0.050 | Why? |  | Nausea | 1 | 2002 | 46 | 0.050 | Why? |  | RNA | 1 | 2002 | 168 | 0.050 | Why? |  | RNA, Messenger | 1 | 2005 | 1132 | 0.050 | Why? |  | Immunohistochemistry | 2 | 2002 | 979 | 0.050 | Why? |  | Graft Survival | 1 | 2002 | 160 | 0.050 | Why? |  | Cerumen | 1 | 2001 | 1 | 0.040 | Why? |  | Pharynx | 1 | 2021 | 31 | 0.040 | Why? |  | Cochlear Aqueduct | 1 | 2000 | 1 | 0.040 | Why? |  | Perilymph | 2 | 2002 | 3 | 0.040 | Why? |  | Anesthetics | 1 | 2000 | 36 | 0.040 | Why? |  | Analysis of Variance | 1 | 2001 | 554 | 0.040 | Why? |  | Preoperative Care | 1 | 2000 | 173 | 0.040 | Why? |  | Neoplasm Staging | 1 | 2002 | 772 | 0.040 | Why? |  | Skull Base | 1 | 1999 | 32 | 0.040 | Why? |  | Endolymphatic Hydrops | 1 | 1998 | 3 | 0.040 | Why? |  | International Agencies | 1 | 2018 | 14 | 0.040 | Why? |  | Brain | 1 | 2007 | 1323 | 0.040 | Why? |  | Bone and Bones | 1 | 2002 | 494 | 0.040 | Why? |  | Surface Tension | 1 | 1998 | 1 | 0.040 | Why? |  | Reproducibility of Results | 1 | 2002 | 1229 | 0.040 | Why? |  | Speech Discrimination Tests | 2 | 1994 | 6 | 0.040 | Why? |  | Acoustics | 1 | 1998 | 34 | 0.040 | Why? |  | Internationality | 1 | 2018 | 43 | 0.040 | Why? |  | Neurosurgical Procedures | 1 | 1999 | 135 | 0.040 | Why? |  | Immunoglobulins | 1 | 1997 | 76 | 0.030 | Why? |  | Parietal Lobe | 1 | 2017 | 26 | 0.030 | Why? |  | Societies, Medical | 1 | 2018 | 200 | 0.030 | Why? |  | Disease Progression | 1 | 2000 | 871 | 0.030 | Why? |  | Food Hypersensitivity | 1 | 1997 | 100 | 0.030 | Why? |  | Autoimmune Diseases | 1 | 1997 | 86 | 0.030 | Why? |  | Premedication | 1 | 1995 | 18 | 0.030 | Why? |  | Nystagmus, Pathologic | 1 | 1995 | 3 | 0.030 | Why? |  | Ethmoid Sinus | 1 | 1995 | 10 | 0.030 | Why? |  | Bone Cysts, Aneurysmal | 1 | 1995 | 5 | 0.030 | Why? |  | Brain Neoplasms | 1 | 1999 | 291 | 0.030 | Why? |  | Electronystagmography | 1 | 1995 | 1 | 0.030 | Why? |  | Speech Reception Threshold Test | 1 | 1995 | 4 | 0.030 | Why? |  | Fibrin Tissue Adhesive | 1 | 1995 | 12 | 0.030 | Why? |  | Frontal Sinus | 1 | 1995 | 9 | 0.030 | Why? |  | Cochlear Microphonic Potentials | 1 | 1995 | 1 | 0.030 | Why? |  | Organ of Corti | 1 | 1995 | 1 | 0.030 | Why? |  | Myelography | 1 | 1995 | 2 | 0.030 | Why? |  | Guinea Pigs | 1 | 1995 | 75 | 0.030 | Why? |  | Bone Transplantation | 1 | 1995 | 42 | 0.030 | Why? |  | Hearing Loss, Central | 1 | 1994 | 4 | 0.030 | Why? |  | Statistics, Nonparametric | 1 | 1995 | 192 | 0.030 | Why? |  | Practice Guidelines as Topic | 1 | 2018 | 488 | 0.030 | Why? |  | Predictive Value of Tests | 1 | 2017 | 944 | 0.030 | Why? |  | Keratinocytes | 1 | 2015 | 93 | 0.030 | Why? |  | Sex Factors | 2 | 1995 | 727 | 0.030 | Why? |  | Anti-Inflammatory Agents | 1 | 1995 | 166 | 0.030 | Why? |  | Electrooculography | 1 | 1993 | 12 | 0.030 | Why? |  | Control Groups | 1 | 2013 | 9 | 0.030 | Why? |  | Linear Models | 1 | 1994 | 287 | 0.030 | Why? |  | Reference Values | 1 | 1994 | 313 | 0.030 | Why? |  | Epithelium | 1 | 1993 | 65 | 0.030 | Why? |  | Immunoenzyme Techniques | 1 | 1993 | 137 | 0.030 | Why? |  | Fascia | 1 | 2013 | 7 | 0.030 | Why? |  | Blood Vessels | 1 | 1993 | 71 | 0.030 | Why? |  | Gambling | 1 | 2013 | 18 | 0.030 | Why? |  | Immunoglobulin G | 1 | 1993 | 195 | 0.030 | Why? |  | Data Interpretation, Statistical | 1 | 2013 | 164 | 0.020 | Why? |  | Impulsive Behavior | 1 | 2013 | 78 | 0.020 | Why? |  | Reward | 1 | 2013 | 115 | 0.020 | Why? |  | Collagen | 1 | 1993 | 211 | 0.020 | Why? |  | Choice Behavior | 1 | 2013 | 83 | 0.020 | Why? |  | Cadaver | 1 | 2012 | 96 | 0.020 | Why? |  | Sensitivity and Specificity | 1 | 1994 | 891 | 0.020 | Why? |  | Rats, Sprague-Dawley | 2 | 2002 | 1563 | 0.020 | Why? |  | Device Removal | 1 | 2005 | 82 | 0.010 | Why? |  | Oval Window, Ear | 1 | 2002 | 2 | 0.010 | Why? |  | Models, Anatomic | 1 | 2002 | 41 | 0.010 | Why? |  | Habituation, Psychophysiologic | 1 | 2002 | 31 | 0.010 | Why? |  | Electromyography | 1 | 2002 | 127 | 0.010 | Why? |  | Pregnancy | 1 | 1988 | 2680 | 0.010 | Why? |  | Osteogenesis | 1 | 2001 | 366 | 0.010 | Why? |  | Osteocytes | 1 | 2001 | 226 | 0.010 | Why? |  | Survival Rate | 1 | 1999 | 945 | 0.010 | Why? |  | Microscopy, Fluorescence | 1 | 1997 | 160 | 0.010 | Why? |  | Headache | 1 | 1995 | 76 | 0.010 | Why? |  | Craniotomy | 1 | 1994 | 31 | 0.010 | Why? | 
 | 
																	
																		
																			
																					
    Dornhoffer's Networks
 
Click the "See All" links for more information and interactive visualizations!
 Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH._ Co-Authors  People in Profiles who have published with this person._ Similar People  People who share similar concepts with this person._ 
            
                Same Department   
				People who are also in this person's primary department.
			 |